TAKASAGO INTERNATIONAL CORPORATION (the “Company”) hereby announces that the Company acquired the Land on June 30, 2025 pursuant to the contract for sale of real estate with Chugai Pharmaceutical Co., Ltd. (Head office: Chuo-ku, Tokyo) .